Roche Offers $43.7B for Remaining Genentech Shares
On Monday, Roche Holdings announced that it is offering $43.7 billion, or $89 per share, to take over the remaining shares of San Francisco-based drugmaker Genentech. Roche already owns 55.9% of Genentech.
- "Roche Offers $44B for Remaining Genentech Shares" (Higgins, AP/San Francisco Chronicle, 7/21).